Medical specialists from France tagged as investigators in clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma
Total 77 results
-
Andre Baruchel, MDSeen in:
- Paris, University Hospital Robert Debre
Trials:- NCT04984356 (Principal Investigator)
-
Anne Jourdain, MDSeen in:
- Tours, Service d'onco-hématologie pédiatrique -CHRU Tours
Trials:- NCT05792007 (Sub-Investigator)
-
Anne Sirvent, MD PhDSeen in:
- Montpellier, Hopital Arnaud de Villeneuve
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Arnaud Petit, M.D.Seen in:
- Paris, CHU Paris Armand Trousseau
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Aurélie CABANNES-HAMYSeen in:
- Paris, CABANNES-HAMY Aurélie
Trials:- NCT03751072 (Principal Investigator)
-
Benedicte Bruno, MD PhDSeen in:
- Lille, CHRU Lille, Service d'Hématologie Pédiatrique
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Camille Leglise, M.D.Seen in:
- Amiens Cedex 1, CHU Amiens Groupe Hospitalier Sud
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Carine HALFON-DOMENECH, M.D, PhDSeen in:
- Lyon Cedex 08, CHU de Lyon HCL - GH Est-Institut d'hématologie et d'oncologie pédiatrique IHOP
- Lyon, Institut d'Hématologie et d'Oncologie Pédiatrique
Trials:- NCT03278145 (Principal Investigator)
- NCT04307576 (Principal Investigator)
-
Caroline Thomas, M.D.Seen in:
- Nantes Cedex 01, CHU Nantes-Hôpital enfant-adolescent
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Catherine Devoldere, M.D.Seen in:
- Amiens Cedex 1, CHU Amiens Groupe Hospitalier Sud
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Catherine Paillard, M.D.Seen in:
- Strasbourg Cedex, CHU Strasbourg -Hôpital de Hautepierre
- Strasbourg, CHU Strasbourg, Service d'hématologie et d'oncologie pédiatrique
Trials:- NCT04307576 (Principal Investigator)
- NCT01949129 (Principal Investigator)
-
Cécile Pochon, M.D.Seen in:
- Nancy, CHU Nancy - Hôpital d'Enfants
- Vandoeuvre-les-nancy cedex, CHU de Nancy - Hôpital de Brabois Enfant
Trials:- NCT04307576 (Principal Investigator)
- NCT01949129 (Principal Investigator)
-
Charlotte Jubert, MD PhDSeen in:
- Bordeaux, CHU Bordeaux
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Christophe Piguet, M.D.Seen in:
- Limoges, Hôpital de la mère et de l'enfant
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Claire Desplantes, M.D.Seen in:
- Dijon, CHU Dijon Hôpital François Mitterrand
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Claire Pluchart, M.D.Seen in:
- Reims, CHU Reims-American Hospital
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Corine Armari AllaSeen in:
- Grenoble Cedex 9, CHU de Grenoble site Nord - Hôpital Albert Michallon
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Damien Bodet, M.D.Seen in:
- Caen Cedex 9, Centre Hospitalier Universitaire Caen
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Dominique Plantaz, MD PhDSeen in:
- Grenoble, CHU Grenoble - Clinique Universitaire de Pédiatrie, Hôpital Couple Enfant
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Emmanuel Gyan, MD-PhDSeen in:
- Tours, Service d'onco-hématologie pédiatrique -CHRU Tours
Trials:- NCT05792007 (Sub-Investigator)
-
Fanny Rialland, MD PhDSeen in:
- Nantes, CHU Nantes, Service d'onco hémato pédiatrie
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Francoise HuguetSeen in:
- Angers, CRLCC Centre Paul Papin
- Midi-pyrenees, Toulouse Cedex 09, Institut Universitaire Du Cancer de Toulouse Oncopole
- Toulouse, University Hospital, Toulouse
Trials:- NCT03589326 (Principal Investigator)
- NCT00188084 (Sub-Investigator)
- NCT05963061 (Sub-Investigator)
-
Frédéric MillotSeen in:
- Poitiers Cedex 6, CHU Poitiers
- Poitiers, Chu Poitiers Chu La Miletrie
Trials:- NCT04307576 (Principal Investigator)
- NCT05180825 (Principal Investigator)
-
Gerard Michel, MD PhDSeen in:
- Marseille, Hopital la Timone Adulte
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Guillaume CARTRON, MD PHDSeen in:
- Montpellier, CHU Montpellier
- Montpellier, Département d'hématologie clinique
Trials:- NCT04703686 (Principal Investigator)
- NCT04290000 (Principal Investigator)
-
Jean-Hugues Dalle, MDSeen in:
- Paris, Hôpital Robert Debré, Paris
Trials:- NCT04785547 (Principal Investigator)
Conditions:
Clinical Trials on Precursor Cell Lymphoblastic Leukemia-Lymphoma
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedAcute Lymphoblastic Leukemia | Precursor B-Cell Lymphoblastic Leukemia | Precursor T-Cell Lymphoblastic LeukemiaUnited States, Australia
-
Bristol-Myers SquibbCompletedLymphoblastic Leukemia, Acute T-cell | Precursor T-Cell Lymphoblastic LymphomaUnited States, France, Germany
-
Asan Medical CenterTerminatedLymphoblastic Lymphoma | Leukemia, Biphenotypic, Acute | Leukemia, Acute Lymphoblastic | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Precursor B-Cell Lymphoblastic LeukemiaKorea, Republic of
-
Beam Therapeutics Inc.RecruitingLymphoblastic Lymphoma | Lymphoblastic Leukemia | T-Cell Lymphoblastic Leukemia/LymphomaUnited States
-
PfizerCompletedLeukemia | Precursor b-Cell Lymphoblastic Leukemia-Lymphoma | ACUTE LYMPHOBLASTIC LEUKEMIAUnited States, Spain, Taiwan, Singapore, India, Hungary, Turkey, Poland
-
Wugen, Inc.RecruitingLymphoblastic Lymphoma | T-cell Acute Lymphoblastic LeukemiaUnited States, Australia, Netherlands, France
-
SanofiTerminatedT-cell Type Acute Leukemia-Precursor | T-lymphoblastic Lymphoma/LeukaemiaHungary, United States, Finland, France, Italy, Lithuania, Russian Federation
-
First Affiliated Hospital of Zhejiang UniversityRecruitingCytarabine+Thiotepa + Fludarabine + Busulfan | T Cell Acute Lymphoblastic Leukemia/Lymphoblastic LymphomaChina
-
920th Hospital of Joint Logistics Support Force...WithdrawnT-lymphoblastic Lymphoma | T-cell Acute Lymphoblastic LeukemiaChina
-
Bambino Gesù Hospital and Research InstituteNot yet recruitingT-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma